JPH0262555B2 - - Google Patents

Info

Publication number
JPH0262555B2
JPH0262555B2 JP55168690A JP16869080A JPH0262555B2 JP H0262555 B2 JPH0262555 B2 JP H0262555B2 JP 55168690 A JP55168690 A JP 55168690A JP 16869080 A JP16869080 A JP 16869080A JP H0262555 B2 JPH0262555 B2 JP H0262555B2
Authority
JP
Japan
Prior art keywords
piperazinyl
mixture
group
added
propyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP55168690A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5692893A (en
Inventor
Takao Takatani
Zenichi Inoe
Nobusachi Yasuda
Masayoshi Murata
Ikuo Ueda
Masaaki Matsuo
Kiryo Tsuji
Masayuki Kato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of JPS5692893A publication Critical patent/JPS5692893A/ja
Publication of JPH0262555B2 publication Critical patent/JPH0262555B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP16869080A 1979-11-30 1980-11-28 Novel cephem compound, its preparation, and preventive and remedy for bacteriosis containing said compound as effective component Granted JPS5692893A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7941417 1979-11-30

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP62137093A Division JPS63115873A (ja) 1979-11-30 1987-05-29 １−置換−１ｈ−テトラゾ−ル−５−チオ−ル化合物およびその塩類

Publications (2)

Publication Number Publication Date
JPS5692893A JPS5692893A (en) 1981-07-27
JPH0262555B2 true JPH0262555B2 (en, 2012) 1990-12-26

Family

ID=10509528

Family Applications (2)

Application Number Title Priority Date Filing Date
JP16869080A Granted JPS5692893A (en) 1979-11-30 1980-11-28 Novel cephem compound, its preparation, and preventive and remedy for bacteriosis containing said compound as effective component
JP62137093A Granted JPS63115873A (ja) 1979-11-30 1987-05-29 １−置換−１ｈ−テトラゾ−ル−５−チオ−ル化合物およびその塩類

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP62137093A Granted JPS63115873A (ja) 1979-11-30 1987-05-29 １−置換−１ｈ−テトラゾ−ル−５−チオ−ル化合物およびその塩類

Country Status (2)

Country Link
US (3) US4420477A (en, 2012)
JP (2) JPS5692893A (en, 2012)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4420477A (en) * 1979-11-30 1983-12-13 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
JPS6041683A (ja) * 1983-07-06 1985-03-05 Asahi Chem Ind Co Ltd 経口用セフアロスボリン誘導体
JP2001131177A (ja) * 1999-11-08 2001-05-15 Ohara Yakuhin Kogyo Kk ジベンズ［ｃ，ｆ］イミダゾ［１，５−ａ］アゼピンの製造方法及びその製造中間体
GB0021898D0 (en) * 2000-09-06 2000-10-25 Celltech Chiroscience Ltd Chemical compounds
DE10046934A1 (de) * 2000-09-21 2002-04-18 Consortium Elektrochem Ind Verfahren zur fermentativen Herstellung von nicht-proteinogenen L-Aminosäuren
DE60234453D1 (de) * 2001-07-02 2009-12-31 High Point Pharmaceuticals Llc Substituierte piperazin- und diazepanderivate zur verwendung als histamin h3 rezeptormodulatoren
SI3616695T1 (sl) 2011-09-09 2025-01-31 Merck Sharp & Dohme Llc Ceftolozan/tazobaktam za zdravljenje intrapulmonalnih okužb
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US20140274997A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Cephalosporin pharmaceutical compositions
MX387913B (es) 2013-03-15 2025-03-19 Merck Sharp & Dohme Llc Composiciones antibioticas de ceftolozano
EP3043797B1 (en) 2013-09-09 2020-04-08 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1075277B (it) * 1977-02-11 1985-04-22 Erba Carlo Spa Derivati insaturi e epossidici dell'acio 7-acilamido-3-cefem-4-carbossilico e procedimento per la loro preparazione
US4182863A (en) * 1974-09-03 1980-01-08 Bristol-Myers Company 7-Amino-3-(1-carboxymethyltetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid
JPS5813539B2 (ja) * 1974-12-12 1983-03-14 藤沢薬品工業株式会社 チカンテトラゾ−ルシボウサンルイノ セイゾウホウ
US4286089A (en) * 1974-12-27 1981-08-25 Smithkline Corporation 7-Acyl-3-(substituted tetrazolyl thiomethyl)cephalosporins
JPS525787A (en) * 1975-06-27 1977-01-17 Bristol Myers Co Antiibacterial agent
NO770703L (no) * 1976-03-03 1977-09-06 Sumitomo Chemical Co Fremgangsm}te for fremstilling av cefalosporiner
DE2760484C2 (en, 2012) * 1976-04-14 1992-12-03 Takeda Chemical Industries, Ltd., Osaka, Jp
JPS52125188A (en) 1976-04-14 1977-10-20 Takeda Chem Ind Ltd Cephalosporin derivatives and their preparation
US4278670A (en) * 1976-07-12 1981-07-14 Smithkline Corporation 7-Alpha-oxyiminoacylcephalosporins
US4117125A (en) * 1977-06-24 1978-09-26 Smithkline Corporation 7-Acylamino-3-[1-[2-(carboxymethylamino]ethyl) tetrazol-5-ylthiomethyl]-3-cephem-4-carboxylic acids
FR2387235A1 (fr) 1978-01-23 1978-11-10 Fujisawa Pharmaceutical Co Procede de preparation de composes d'acide 3,7-disubstitue-3-cephem-4-carboxylique et nouveaux produits ainsi obtenus, ayant une forte activite antibacterienne
JPS54103888A (en) * 1978-02-01 1979-08-15 Toyama Chem Co Ltd Novel 7alpha-methoxy-cephalosporin
JPS54144392A (en) * 1978-05-04 1979-11-10 Asahi Chem Ind Co Ltd Cephalosporin derivative
FR2448543A1 (fr) * 1979-02-09 1980-09-05 Roussel Uclaf Nouvelles oximes o-substituees par un radical comportant un ammonium quaternaire et derivees de l'acide 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
EP0095029B1 (en) * 1979-11-30 1986-11-05 Fujisawa Pharmaceutical Co., Ltd. 5-thio-tetrazol compounds and their preparation
US4420477A (en) * 1979-11-30 1983-12-13 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds

Also Published As

Publication number Publication date
US4420477A (en) 1983-12-13
US4582908A (en) 1986-04-15
JPS63115873A (ja) 1988-05-20
JPS5692893A (en) 1981-07-27
US4493834A (en) 1985-01-15
JPH0242829B2 (en, 2012) 1990-09-26

Similar Documents

Publication Publication Date Title
EP0057422B1 (en) New cephem compounds, processes for preparation thereof and pharmaceutical composition containing them
EP0001125B1 (en) Cephalosporin derivatives, processes for their preparation and pharmaceutical compositions containing them
US4639448A (en) 7-amino-3-[substituted vinyl]-3-cephem-4-carboxylates having antimicrobial activity
EP0007633A2 (en) Cephem compounds, processes for their preparation and pharmaceutical compositions containing them
US4366153A (en) Cephem compounds
JPH0262555B2 (en, 2012)
EP0184227B1 (en) 2-oxymino 2-aminothiazolyl acetic acid derivatives and processes for preparation thereof
EP0008442B1 (en) 2-lower alkyl-7-substituted-2 or 3-cephem-4-carboxylic acid compounds, processes for their preparation and pharmaceutical compositions containing them
US4761410A (en) Cephem Compounds
EP0010313B1 (en) 3,7-disubstituted-2- or -3-cephem-4-carboxylic acid compounds, pharmaceutical compositions containing them and processes for the preparation thereof
US4299829A (en) 2-Lower alkyl-7-substituted-2 or 3-cephem 4-carboxylic acid compounds
US4152433A (en) 2-Lower alkyl-7-substituted-2 or 3-cephem-4-carboxylic acid compounds and pharmaceutical compositions
US4443443A (en) Cephem compounds
US4563450A (en) Cephem compounds
US4225707A (en) 2-Lower alkyl-7-substituted-2 or 3-cephem-4-carboxylic acid compounds
JPH0240678B2 (en, 2012)
JPS6361954B2 (en, 2012)
US4191762A (en) 2-Lower alkyl-7-substituted amino-2 or 3-cephem-4-carboxylic acid compounds
EP0029998B1 (en) Cephem compounds, processes for their preparation and pharmaceutical compositions containing them
JP2518546B2 (ja) 新規セフェム化合物
JPH0359076B2 (en, 2012)
JPH0337557B2 (en, 2012)
JPS62238291A (ja) セフエム化合物および医薬として許容されるその塩
JPS62283979A (ja) 新規セフエム化合物およびその塩